We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Benchtop-Sized Image Cytometry System Brings Advanced Cell Analysis into the Lab

By LabMedica International staff writers
Posted on 01 May 2012
The first months in a year bring with it the opportunity for biotech research and other life science laboratories to acquire a new, state-of-the-art benchtop-sized image cytometer for rapid cell characterization.

Image cytometry generates microscopic cellular images and uses image-processing techniques to quantify cell data. More...
The technique can be used to acquire fluorescent intensity data from labeled cell samples, as well as for gathering morphological information. These basic principles can be applied to systems designed for a wide range of applications, up to and including high throughput screening of cell samples.

In order to meet the increasing need for convenient assays that deliver detailed multiparameter cell data quickly at laboratory scale, GE Healthcare (Chalfont St. Giles, United Kingdom) has introduced the Cytell Image Cytometer.

This benchtop-sized image cytometer is able to measure more than 32 parameters in a single run. Red and blue lasers (640- and 488-nm excitation) and four detectors enable a wide range of dyes to be used, including acridine orange, GFP, FITC, Alexa FluorTM 488, Phycoerythrin (PE), Propidium iodide (PI), Cy3, Cy5, Alexa Fluor 647, Allophycocyanin (APC), Dy649, DRAQ7TM, Dy679, and Alexa Fluor 700 with simultaneous measurement of four fluorescent channels. This array enables the researcher to perform a multitude of analyses including cell count, cell viability, and apoptosis; cell surface marker assays; antibody detection assays; cell phenotype analysis; and cell subpopulation analysis. In addition, Cytell was designed as an open platform allowing the investigator to use in-house reagents, antibodies, and protocols through an intuitive and simple interface.

Data can be acquired for up to eight samples at a time, and results are delivered through an intuitive graphical interface in less than two-and-a-half minutes.

Dr. Amr Abid, general manager of cell technologies at GE Healthcare Life Sciences, said, “We believe that understanding life’s basic building block, the cell, is an essential first step in the development of new and more effective treatments for disease. The Cytell Image Cytometer complements our existing advanced cell imaging systems, the IN Cell Analyzer and the DeltaVision OMX, by providing a quick and simple option for cell analysis. It is often the small changes that make the difference, and we believe that the Cytell will help researchers save both time and money in an increasingly constrained funding environment.”

Related Links:
GE Healthcare


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.